Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Precious Cargo: Nanotechnology enlists silk, diamonds and gold to improve molecular medicine

Nanomedicine incorporates some of the most prized materials on earth in order to improve not only its biocompatibility and imaging potential, but its ability to sneak up on and change the way that cells function for the tiniest aspect of personalized medicine.

Thumbnail

Single Database, Multiple Benefits: San Gabriel Valley Diagnostic Center

RamSoft

San Gabriel Valley Diagnostic Center (SGVDC) of West Covina, Calif., made its transition to digital imaging comparatively early, installing a PowerServer PACS from RamSoft in January of 2006.

New $15M biomarker lab planned for Singapore

Los Angeles-based ImaginAb is slated to collaborate with Duke-NUS Graduate School of Medicine and National Research Foundation Corp Lab on a $15 million imaging biomarker lab, ImaginAb announced Feb. 10.

Sedecal and Xstrahl partner on pre-clinical systems

A distribution contract has been struck between preclinical molecular imaging system manufacturer Sedecal headquartered in Spain and United Kingdom radiation oncology systems manufacturer Xstrahl Life Sciences, the company announced today.

Novel immuno-PET agent seeks cancer vasculature

An investigational immune-PET biomarker maps tumor vasculature while skipping healthy tissues, according to a study published Feb. 13 in the Journal of Nuclear Medicine.

Dual therapy proven to improve survival in patients with glioma

Following radiation therapy with chemotherapy has now been shown to prolong survival for glioma patients. Results of the study were announced Feb. 3 by the National Institutes of Health.

Edinburgh Molecular Imaging gets more than $6M in funding for optical innovation

The Scottish developer of optical molecular imaging technology, Edinburgh Molecular Imaging, has received venture capital funding amounting to more than $6 million, the University of Edinburgh announced Feb 7.

Thumbnail

Improving breast cancer outcomes: FDG PET peers in on adrenoceptor blockers

Adrenoceptor blockers have been found to stave off metastasis and recurrence of breast cancer. This may be due to their interruption of key genes involved in glucose metabolism as visualized by FDG-PET, according to a study published Feb. 6 in the Journal of Nuclear Medicine.